EVA: Evista Alendronate Comparison

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

NCT00383422 ·Status: COMPLETED ·Phase: PHASE3

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

NCT00541658 ·Status: COMPLETED ·Phase: PHASE3

A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)

NCT00389740 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis

NCT00670319 ·Status: COMPLETED ·Phase: PHASE3

A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis

NCT01128257 ·Status: COMPLETED

The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.

NCT00346190 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer

NCT03324932 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover

NCT04403698 ·Status: COMPLETED ·Phase: PHASE2

A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.

NCT00330460 ·Status: COMPLETED ·Phase: PHASE3

Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women

NCT00504166 ·Status: COMPLETED ·Phase: PHASE4

Osteoporosis Prevention With Low Dose Alendronate

NCT00463268 ·Status: COMPLETED ·Phase: PHASE3

Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation

NCT00790101 ·Status: TERMINATED ·Phase: PHASE4

A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)

NCT00092014 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®

NCT05405725 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis

NCT01544894 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose

NCT00577850 ·Status: COMPLETED ·Phase: PHASE1

Effects of Teriparatide in Postmenopausal Women With Osteoporosis

NCT00079924 ·Status: COMPLETED ·Phase: PHASE4

A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)

NCT00092040 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women

NCT01343004 ·Status: COMPLETED ·Phase: PHASE3

A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.

NCT00503113 ·Status: COMPLETED ·Phase: PHASE4

Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

NCT00136058 ·Status: COMPLETED ·Phase: PHASE3

Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects

NCT00666627 ·Status: COMPLETED ·Phase: PHASE2

A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women

NCT00860964 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation

NCT05405894 ·Status: ACTIVE_NOT_RECRUITING

A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis

NCT02598440 ·Status: COMPLETED ·Phase: PHASE4